Subscribe to Bio.News Weekly Newsletter
Get Bio.News in your inbox every Monday morning.
SubscribeNo spam. Just science. Unsubscribe at any time.
WATCH THE LATEST FROM BIO.NEWS
Latest News
BIO responds to Health Affairs Analysis, highlighting the importance of orphan drug incentives
Orphan drug development is one of the more fraught undertakings in biomedical research. Targeting rare diseases often requires cutting-edge science,...
Patient Advocacy Coffee Chat: Basic steps to being a good advocate
“What does good advocacy look like? Why do we advocate? And what are some tips and tricks for effective advocacy?”...
PACE panel notes challenges IRA poses for patients
Changes brought on by the Inflation Reduction Act (IRA) often increase patient costs and reduce access, while also harming the...
CDC report details impact of AMR pathogens
The most dangerous antimicrobial-resistant (AMR) pathogens in America are causing an estimated 9.7 million infections and 50,800 deaths in the...
BIO supports FDA’s new Fit-for-Purpose Rare Disease Framework Initiative
BIO praised a Food and Drug Administration (FDA) initiative targeting more tailored, patient-centered, and predictable development of rare disease drugs,...
IP: American as apple pie and essential for biotech
The United States leads the world in biotech innovation, and a major driver is its strong intellectual property (IP) system....